<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03871400</url>
  </required_header>
  <id_info>
    <org_study_id>SS-NM-1801</org_study_id>
    <nct_id>NCT03871400</nct_id>
  </id_info>
  <brief_title>The NanoStrand Clinical Study</brief_title>
  <official_title>Comparison of Early Fusion Using a NanoMetalene® Implant Versus Both PEEK and Allograft Implants in Anterior Cervical Discectomy and Fusion (ACDF) With OsteoStrand™ Demineralized Bone Fibers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SeaSpine, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SeaSpine, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multi-center, randomized, self-controlled, single-blinded, clinical study
      evaluating the NanoMetalene implant as compared to the PEEK and allograft implants in ACDF
      for the treatment of cervical degenerative disc disease (DDD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PEEK: Polyetheretherketone ACDF: Anterior cervical discectomy and fusion
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 18, 2018</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of cervical spinal levels for NanoMetalene vs PEEK interbody implants that have achieved fusion as determined by Computed Tomography (CT) analysis</measure>
    <time_frame>12 months</time_frame>
    <description>Proportion of cervical spinal levels for NanoMetalene vs PEEK interbody implants that have achieved fusion as determined by Computed Tomography (CT) analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary CT Analysis: PEEK</measure>
    <time_frame>12 months</time_frame>
    <description>Proportion of cervical spinal levels for NanoMetalene vs PEEK interbody implants that have achieved fusion as determined by Computed Tomography (CT) analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary CT Analysis: Allograft</measure>
    <time_frame>12 months</time_frame>
    <description>Proportion of cervical spinal levels for NanoMetalene vs Allograft implants that have achieved fusion as determined by Computed Tomography (CT) analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary X-Ray Analysis</measure>
    <time_frame>24 months</time_frame>
    <description>Proportion of cervical spinal levels for NanoMetalene vs PEEK and Allograft implants that have achieved fusion as determined by x-ray analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcomes: NDI</measure>
    <time_frame>24 months</time_frame>
    <description>Improvement of clinical outcomes (NDI) for all enrolled patients. Improvement is a reduction of scores for all clinical outcomes. Results will be shown as change from baseline to 24 month follow-up.
The NDI is an index derived from the Neck Disability Index Pain Questionnaire used by surgeons, clinicians and researchers to quantify disability for neck pain. Scores are from 0-100 and a lower score represents a better score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcomes: VAS Arm</measure>
    <time_frame>24 months</time_frame>
    <description>Improvement of clinical outcomes (VAS Arm) for all enrolled patients. Improvement is a reduction of scores for all clinical outcomes. Results will be shown as change from baseline to 24 month follow-up.
The visual analogue scale (VAS) is a commonly used outcome measure for research studies. It is presented as a 100-mm horizontal line on which the patient's pain intensity is represented by a point between the extremes of &quot;0&quot;/no pain at all&quot; and &quot;100/worst pain imaginable.&quot; The study in this scale is used for the worst arm pain. A lower score represents a better score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcomes: VAS Neck</measure>
    <time_frame>24 months</time_frame>
    <description>Improvement of clinical outcomes (VAS Neck) for all enrolled patients. Improvement is a reduction of scores for all clinical outcomes. Results will be shown as change from baseline to 24 month follow-up.
The visual analogue scale (VAS) is a commonly used outcome measure for research studies. It is presented as a 100-mm horizontal line on which the patient's pain intensity is represented by a point between the extremes of &quot;0&quot;/no pain at all&quot; and &quot;100/worst pain imaginable.&quot; The study in this scale is used for neck pain. A lower score represents a better score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Disc Degeneration;Cervical</condition>
  <arm_group>
    <arm_group_label>NanoMetalene/PEEK</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>NanoMetalene/Allograft</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Anterior cervical discectomy and fusion</intervention_name>
    <description>primary, 2-level, contiguous</description>
    <arm_group_label>NanoMetalene/Allograft</arm_group_label>
    <arm_group_label>NanoMetalene/PEEK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cervical degenerative disc disease

          -  Requires primary spinal fusion from C3-C7

          -  Minimum of 6 weeks of non-operative treatment

          -  Signed informed consent form

        Exclusion Criteria:

          -  Uncontrolled type I or II diabetes mellitus

          -  Morbid obesity

          -  Documented history of alcohol or drug abuse

          -  Fever or leukocytosis

          -  Current systemic infection

          -  Active malignancy and/or current chemotherapy

          -  Known history of osteoporosis

          -  Prior fusion or total disc replacement at the operative level or an adjacent level

          -  Infection of the operative site

          -  Use of implants from other systems

          -  Pregnancy

          -  Participation in another research study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khalid Abbed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barrow Brain and Spine</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odilette Trevizo, RN, BSN</last_name>
      <phone>877-867-9860</phone>
      <email>Odilette.Trevizo@DignityHealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesal Parekh, PhD</last_name>
      <phone>858-657-8200</phone>
      <email>jeparekh@ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emi Hirsh, BS</last_name>
      <phone>800-872-2273</phone>
      <email>emi.hirsh@med.usc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCLA Health</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madeline Cross</last_name>
      <phone>310-319-3475</phone>
      <email>MCross@mednet.ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Cofer</last_name>
      <phone>720-848-1980</phone>
      <email>Claire.Cofer@cuanschutz.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jill Fattor</last_name>
      <phone>720-848-1980</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Spine Colorado</name>
      <address>
        <city>Durango</city>
        <state>Colorado</state>
        <zip>81301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliana Hill</last_name>
      <phone>970-382-9500</phone>
      <email>jhill@spinecolorado.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Gleeny</last_name>
      <phone>404-778-7000</phone>
      <email>lauren.glenney@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hughston Clinic</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivey Holt</last_name>
      <phone>706-324-6661</phone>
      <email>webmaster@hughston.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashkan Zarrieneh</last_name>
      <phone>312-695-0482</phone>
      <email>Ashkan.Zarrieneh@nm.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OrthIndy</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46278</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Molly Miller</last_name>
      <phone>317-802-2883</phone>
      <email>molmiller@orthoindy.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henry Ford</name>
      <address>
        <city>Jackson</city>
        <state>Michigan</state>
        <zip>49201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Schmidt</last_name>
      <phone>517-205-4800</phone>
      <email>hschmid5@hfhs.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 8, 2019</study_first_submitted>
  <study_first_submitted_qc>March 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>March 5, 2020</last_update_submitted>
  <last_update_submitted_qc>March 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

